UNODC World Drug Report 2024
A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and analysis and in 2024 comprises several elements tailored to different audiences.
Evaluation
European Drug Report 2024: Trends and Developments
The European Drug Report 2024: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report provides a comprehensive set of national...
Spanish Project of Best Practice Portal in Drug Demand Reduction and Behavioural Addictions
INTRODUCTION: In Spain, the offer of prevention programmes is very varied and structured, but today the challenge remains how to put evidence into practice. European Commission define a best practice as “a relevant policy or intervention...
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain
There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence of lifetime trauma and differences by gender, PTSD status, and chronic pain.
Spanish University Postgraduate Training on Addictions: The Historic Development and its Current Situation
BACKGROUND: Drug dependence is a public health problem that requires trained professionals to effectively address this issue. The aim of this study was to analyse postgraduate university training programs specialising in addictions in Spain...
Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation
Background: Over the past decade, drug-related overdoses have seen a significant rise both in North America and globally. The COVID-19 pandemic has further emphasised the urgent need for safer supply programs to replace unregulated...
Rehabilitation of Executive Functions in Users of Addictive Substances. Study Protocol
BACKGROUND: Substance use increases the risk of damage to executive and cognitive functions. Manifested by a range of clinical symptoms, such impairments may affect people’s coping with everyday activities and their abilities to establish...
DIMS Annual Report 2022
The DIMS annual report 2022 covers the concentrations, adulterations, and other relevant information produced by DIMS in the past year, and in doing so forms a topical image of the Dutch drug market. Spread out over all Dutch provinces, the...
Open Consultation: UK clinical guidelines for alcohol treatment
The consultation on the UK clinical guidelines for alcohol treatment is now open. Consultation description This consultation asks you to review individual chapters from the draft UK clinical guidelines for alcohol treatment. Each chapter of...
Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway
Background: Physical health problems are common in people receiving opioid agonist treatment (OAT). A study was conducted on these health issues in OAT patients in the Czech Republic and Norway from 2010 to 2019, with a focus on gender...